THL investment values Bazaarvoice at $1.5b-plus, Ares gains secondaries business through $1b Landmark acquisition, Avista sees opportunity to simplify early-stage drug-development
THL's investment in Bazaarvoice puts company at an over $1.5 billion valuation and Ares agrees to buy secondaries shop Landmark Partners.
31 March 2021•2 mins read
